Basics |
TransMedics Group, Inc.
|
IPO Date: |
April 29, 2019 |
Sector: |
Healthcare |
Industry: |
Medical Devices |
Market Cap: |
$4.35B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$1.38 | 2.86%
|
Avg Daily Range (30 D): |
$2.16 | 2.07%
|
Avg Daily Range (90 D): |
$2.33 | 3.00%
|
Institutional Daily Volume |
Avg Daily Volume: |
.49M |
Avg Daily Volume (30 D): |
1M |
Avg Daily Volume (90 D): |
1.1M |
Trade Size |
Avg Trade Size (Sh.): |
53 |
Avg Trade Size (Sh.) (30 D): |
43 |
Avg Trade Size (Sh.) (90 D): |
46 |
Institutional Trades |
Total Inst.Trades: |
2,574 |
Avg Inst. Trade: |
$3.32M |
Avg Inst. Trade (30 D): |
$4.9M |
Avg Inst. Trade (90 D): |
$3.63M |
Avg Inst. Trade Volume: |
.04M |
Avg Inst. Trades (Per Day): |
2 |
Market Closing Trades |
Avg Closing Trade: |
$5.38M |
Avg Closing Trade (30 D): |
$7.52M |
Avg Closing Trade (90 D): |
$7.19M |
Avg Closing Volume: |
63.5K |
|
|
|
|
Financials |
|
TTM |
Q3 2024 |
Q2 2024 |
Basic EPS
|
$.76
|
$.13
|
$.37
|
Diluted EPS
|
$.7
|
$.12
|
$.35
|
Revenue
|
$ 143.54M
|
$ 108.76M
|
$ 114.31M
|
Gross Profit
|
$ 88.23M
|
$ 60.85M
|
$ 69.26M
|
Net Income / Loss
|
$ 25.68M
|
$ 4.22M
|
$ 12.19M
|
Operating Income / Loss
|
$ 27.44M
|
$ 3.92M
|
$ 12.51M
|
Cost of Revenue
|
$ 55.31M
|
$ 47.92M
|
$ 45.04M
|
Net Cash Flow
|
$ -26.51M
|
$ -32.66M
|
$ 12.53M
|
PE Ratio
|
177.60
|
|
|
|